Japan Tissue Engineering Co., Ltd. provided earnings guidance for the year ending March 31, 2023. For the year, the company expects net sales of ¥2,540 million, operating loss of ¥389 million and net loss of ¥388 million or ¥9.57 per share.
Japan Tissue Engineering Co., Ltd.
Equities
7774
JP3389610001
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
615 JPY | +0.49% | +4.41% | +21.74% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.74% | 156M | |
+10.11% | 127B | |
-5.15% | 11.34B | |
+6.07% | 9.11B | |
+37.46% | 5.53B | |
+8.53% | 3.45B | |
-8.69% | 2.87B | |
-6.38% | 2.1B | |
-10.91% | 2.08B | |
-23.21% | 1.78B |
- Stock Market
- Equities
- 7774 Stock
- News Japan Tissue Engineering Co., Ltd.
- Japan Tissue Engineering Co., Ltd. Provides Earnings Guidance for the Year Ending March 31, 2023